LPL Financial’s Allena Pharmaceuticals ALNA Stock Holding History

LPL Financial’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,550	Closed	-$6K	–	4568
2022 Q2	$6K	Hold	30,550	–	–	﹤0.01%	4400
2022 Q1	$7K	Hold	30,550	–	–	﹤0.01%	4162
2021 Q4	$18K	Hold	30,550	–	–	﹤0.01%	4297
2021 Q3	$28K	Buy	30,550 +5,500	+22%	+$5.38K	﹤0.01%	4270
2021 Q2	$33K	Hold	25,050	–	–	﹤0.01%	4172
2021 Q1	$35K	Hold	25,050	–	–	﹤0.01%	4023
2020 Q4	$32K	Buy	25,050 +50	+0.2%	+$70	﹤0.01%	3761
2020 Q3	$37K	Hold	25,000	–	–	﹤0.01%	3461
2020 Q2	$40K	Buy	+25,000	New	+$42K	﹤0.01%	3369

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LPL Financial's ALNA Position: Q3 2022 in Review

LPL Financial sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 30,550 shares — an estimated $6K sold.

LPL Financial first reported a position in ALNA in Q2 2020 and held it in 9 quarters. The position peaked at $40K in Q2 2020. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

LPL Financial reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
LPL Financial sold 30,550 Allena Pharmaceuticals shares in Q3 2022, an estimated $6K.
LPL Financial first reported a position in Allena Pharmaceuticals in Q2 2020 and held it in 9 quarters.
LPL Financial's Allena Pharmaceuticals position peaked at $40K in Q2 2020.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on LPL Financial's 13F filing for Q3 2022, filed 14 Nov 2022.